BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32447493)

  • 21. Langerhans cell counts in oral epithelial dysplasia and their correlation to clinicopathological parameters.
    Wang YP; Chen IC; Wu YH; Wu YC; Chen HM; Yu-Fong Chang J
    J Formos Med Assoc; 2017 Jun; 116(6):457-463. PubMed ID: 28292622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of Binary System with Ki67 Immunohistochemical Staining: a Reliable Grading Method for Oral Epithelial Dysplasia.
    Akafzadeh N; Baghaei F; Derakhshan S; Moradzadeh Khiavi M; Kharazifard M; Aminishakib P
    J Dent (Shiraz); 2022 Sep; 23(2 Suppl):377-382. PubMed ID: 36588968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of malignant transformation and recurrence of oral epithelial dysplasia using architectural and cytological feature specific prognostic models.
    Mahmood H; Bradburn M; Rajpoot N; Islam NM; Kujan O; Khurram SA
    Mod Pathol; 2022 Sep; 35(9):1151-1159. PubMed ID: 35361889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of oral epithelial dysplasia managed by observation versus excision.
    Bernard C; Zhang JZ; Klieb H; Blanas N; Xu W; Magalhaes M
    Head Neck; 2023 Dec; 45(12):3096-3106. PubMed ID: 37800675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology.
    Müller S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):591-602. PubMed ID: 29606637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra.
    Ellis BG; Whitley CA; Triantafyllou A; Gunning PJ; Smith CI; Barrett SD; Gardner P; Shaw RJ; Weightman P; Risk JM
    PLoS One; 2022; 17(3):e0266043. PubMed ID: 35333891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathological findings of oral epithelial dysplasias and their relation to malignant transformation.
    Ellonen R; Suominen A; Kelppe J; Willberg J; Rautava J; Laine H
    Cancer Treat Res Commun; 2023; 34():100664. PubMed ID: 36481601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Update on the Use of Artificial Intelligence in Digital Pathology for Oral Epithelial Dysplasia Research.
    Alajaji SA; Khoury ZH; Jessri M; Sciubba JJ; Sultan AS
    Head Neck Pathol; 2024 May; 18(1):38. PubMed ID: 38727841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interobserver agreement in dysplasia grading: toward an enhanced gold standard for clinical pathology trials.
    Speight PM; Abram TJ; Floriano PN; James R; Vick J; Thornhill MH; Murdoch C; Freeman C; Hegarty AM; D'Apice K; Kerr AR; Phelan J; Corby P; Khouly I; Vigneswaran N; Bouquot J; Demian NM; Weinstock YE; Redding SW; Rowan S; Yeh CK; McGuff HS; Miller FR; McDevitt JT
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Oct; 120(4):474-82.e2. PubMed ID: 26216170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral epithelial dysplasia grading: Comparing the binary system to the traditional 3-tier system, an actuarial study with malignant transformation as outcome.
    Sperandio M; Warnakulasuriya S; Soares AB; Passador-Santos F; Mariano FV; Lima CSP; Scarini JF; Dominguete MHL; de Camargo Moraes P; Montalli VAM; Hellmeister L; de Araújo VC
    J Oral Pathol Med; 2023 May; 52(5):418-425. PubMed ID: 36177736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up.
    Arduino PG; Surace A; Carbone M; Elia A; Massolini G; Gandolfo S; Broccoletti R
    J Oral Pathol Med; 2009 Jul; 38(6):540-4. PubMed ID: 19453839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inter- and intra-observer variability in three grading systems for oral epithelial dysplasia.
    Krishnan L; Karpagaselvi K; Kumarswamy J; Sudheendra US; Santosh KV; Patil A
    J Oral Maxillofac Pathol; 2016; 20(2):261-8. PubMed ID: 27601820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
    Sperandio M; Brown AL; Lock C; Morgan PR; Coupland VH; Madden PB; Warnakulasuriya S; Møller H; Odell EW
    Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical determinants of malignant transformation in oral epithelial dysplasia.
    Ho MW; Risk JM; Woolgar JA; Field EA; Field JK; Steele JC; Rajlawat BP; Triantafyllou A; Rogers SN; Lowe D; Shaw RJ
    Oral Oncol; 2012 Oct; 48(10):969-976. PubMed ID: 22579265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
    Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
    Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of FANCD2 and related proteins may predict malignant transformation in oral epithelial dysplasia.
    Ho MW; Ryan MP; Gupta J; Triantafyllou A; Risk JM; Shaw RJ; Wilson JB
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Apr; 133(4):377-387. PubMed ID: 34493474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders.
    Sharada P; Swaminathan U; Nagamalini BR; Kumar KV; Ashwini BK; Lavanya V
    J Oral Maxillofac Pathol; 2018; 22(1):40-47. PubMed ID: 29731555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of specific clinical risk factors associated with the malignant transformation of oral epithelial dysplasia.
    Kierce J; Shi Y; Klieb H; Blanas N; Xu W; Magalhaes M
    Head Neck; 2021 Nov; 43(11):3552-3561. PubMed ID: 34472151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential Immunohistochemical Biomarkers for Grading Oral Dysplasia: A Literature Review.
    Zdrojewski J; Nowak M; Nijakowski K; Jankowski J; Scribante A; Gallo S; Pascadopoli M; Surdacka A
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.